Calcineurin in human heart hypertrophy

Circulation

Volumn 105, Issue 19, 2002, Pages 2265-2269

  Ritter, Oliver ^a   Hack, Susanne ^a   Schuh, Kai ^a   Röthlein, Nicola ^a   Perrot, Andreas ^a   Osterziel, Karl J ^a   Schulte, Hagen D ^a   Neyses, Ludwig ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cardiomyopathy; Hypertrophy; Signal transduction

Indexed keywords

CALCINEURIN;

ARTICLE; CONGESTIVE HEART FAILURE; ENZYME ACTIVITY; HEART HYPERTROPHY; HUMAN; HUMAN TISSUE; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AORTIC VALVE STENOSIS; BLOTTING, WESTERN; CALCINEURIN; CARDIOMEGALY; CARDIOMYOPATHY, HYPERTROPHIC; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HUMANS; MYOCARDIUM; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0037076286     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000016044.19527.96     Document Type: Article

References (23)

1. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
2. Calcineurin and human heart failure
3. Revisiting calcineurin and human heart failure
4. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure
5. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy: Late results up to twenty-five years
6. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy
7. Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats
8. Prevention of cardiac hypertrophy in mice by calcineurin inhibition
9. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy
10. Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training
11. Cardiac calcineurin during transition from hypertrophy to heart failure in rats
12. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure
13. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats
14. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin
15. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin
16. Functional domain structure of calcineurin A: Mapping by limited proteolysis
17. Low affinity Ca2+-binding sites of calcineurin B mediate conformational changes in calcineurin A
18. Molecular and cellular mechanisms of myocardial stunning
19. Characterization of the fragmented forms of calcineurin produced by calpain I
20. Transcription factors of the NFAT family: Regulation and function
21. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity
22. Calcineurin inhibition and cardiac hypertrophy: A matter of balance
23. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo